nWay partners with WWE, page-7

First 7 Last

Share
Profile

Follow
mr_delta

12,302 Posts.

1318

13/07/20

14:46

Post #: 45827996
Share

Originally posted by Grinder57: ↑

Appears to be pretty substantial licensing deal!

I went ahead an acquired some shares on the Primary Markets last week, couldn’t help myself as at .10c A is where the share price in October of 2018!

”Back to the Future”...

For me I have seen Versus recently trade shares with Animoca @ .18 c A and now GAMEE agreeing to a mostly all stock deal where their entire company was acquired for .18c A share price!

There is still plenty of risk, so it’s not for everyone!

Good Luck and so delighted to see the Company making strides forward !

all above just my opinion

Expand

nice !

10c is a great outcome for you (not for the seller though )... but I guess if someone wants to sell out, then this is a good platform to trade for them...

I think we will not see the AB1 IPO this side of 2020... earliest I can see it happen is in 2021 Q1... so you are taking some risk too... which hopefully pays you a decent premium in the next 6-9 months...

I would like the company to come out with the listing news ASAP... the whole process should take 16-20 weeks once they come out with the details... so the more late that first news comes out, the later will we relist...

AB1 Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

nWay partners with WWE, page-7

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News